References in periodicals archive ?
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.
Non-hodgkin's Lymphoma Preclinical Research Pipeline Insights
The preliminary Phase II study, initiated in mid-1998, was designed to evaluate ATRAGEN's ability to induce a response in relapsed or refractory non-Hodgkin's lymphoma patients.
Finally, she observes that although AIDS, organ transplantation, and certain rare genetic disorders appear to predispose individuals to developing non-Hodgkin's lymphomas, these risk factors "couldn't begin to explain the level of increased incidence that has occurred throughout the world.
Cancer patients with a confirmed diagnosis of multiple myeloma or non-Hodgkin's lymphoma may be eligible to participate in new treatment studies at UCI.
These initial findings support that SAR3419 offers potential for the treatment of B-cell non-Hodgkin's lymphoma, including rituximab-refractory disease," commented John Lambert, PhD, Executive Vice President and Chief Scientific Officer, ImmunoGen.
During the 7-year study, 104 of the women developed non-Hodgkin's lymphoma.
LYM-1 could be an important contribution as an additional agent for the treatment of Non-Hodgkin's Lymphoma," said Dr.
OTCBB: BVTI; "Biovest"), the commercial launch of the AutovaxID[TM] device, and the continued development of another potential blockbuster product, BiovaxID[TM], a personalized therapeutic anti-cancer vaccine for follicular non-Hodgkin's lymphoma.
In February, researchers reported that women who had relied on black hair dye for 20 years or longer ran a slightly increased risk of dying from certain blood-based cancers, such as non-Hodgkin's lymphoma (SN: 2/5/94, p.
The trials, conducted at Dana-Farber Cancer Institute in Boston, involve relapsed patients with Non-Hodgkin's lymphoma or lymphocytic leukemias.